These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 31068482)
1. Elevated cerebrospinal fluid total tau in former professional athletes with multiple concussions. Taghdiri F; Multani N; Tarazi A; Naeimi SA; Khodadadi M; Esopenko C; Green R; Colella B; Wennberg R; Mikulis D; Davis KD; Goswami R; Tator C; Levine B; Tartaglia MC Neurology; 2019 Jun; 92(23):e2717-e2726. PubMed ID: 31068482 [TBL] [Abstract][Full Text] [Related]
2. Assessment of Racial Disparities in Biomarkers for Alzheimer Disease. Morris JC; Schindler SE; McCue LM; Moulder KL; Benzinger TLS; Cruchaga C; Fagan AM; Grant E; Gordon BA; Holtzman DM; Xiong C JAMA Neurol; 2019 Mar; 76(3):264-273. PubMed ID: 30615028 [TBL] [Abstract][Full Text] [Related]
3. Decreased beta-amyloid1-42 and increased tau levels in cerebrospinal fluid of patients with Alzheimer disease. Sunderland T; Linker G; Mirza N; Putnam KT; Friedman DL; Kimmel LH; Bergeson J; Manetti GJ; Zimmermann M; Tang B; Bartko JJ; Cohen RM JAMA; 2003 Apr 23-30; 289(16):2094-103. PubMed ID: 12709467 [TBL] [Abstract][Full Text] [Related]
4. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease. Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038 [TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal Fluid Markers of Alzheimer's Disease Pathology and Microglial Activation are Associated with Altered White Matter Microstructure in Asymptomatic Adults at Risk for Alzheimer's Disease. Melah KE; Lu SY; Hoscheidt SM; Alexander AL; Adluru N; Destiche DJ; Carlsson CM; Zetterberg H; Blennow K; Okonkwo OC; Gleason CE; Dowling NM; Bratzke LC; Rowley HA; Sager MA; Asthana S; Johnson SC; Bendlin BB J Alzheimers Dis; 2016; 50(3):873-86. PubMed ID: 26836182 [TBL] [Abstract][Full Text] [Related]
6. Association of Cerebrospinal Fluid (CSF) Insulin with Cognitive Performance and CSF Biomarkers of Alzheimer's Disease. Geijselaers SLC; Aalten P; Ramakers IHGB; De Deyn PP; Heijboer AC; Koek HL; OldeRikkert MGM; Papma JM; Reesink FE; Smits LL; Stehouwer CDA; Teunissen CE; Verhey FRJ; van der Flier WM; Biessels GJ; J Alzheimers Dis; 2018; 61(1):309-320. PubMed ID: 29154275 [TBL] [Abstract][Full Text] [Related]
7. Diffuse white matter tract abnormalities in clinically normal ageing retired athletes with a history of sports-related concussions. Tremblay S; Henry LC; Bedetti C; Larson-Dupuis C; Gagnon JF; Evans AC; Théoret H; Lassonde M; De Beaumont L Brain; 2014 Nov; 137(Pt 11):2997-3011. PubMed ID: 25186429 [TBL] [Abstract][Full Text] [Related]
8. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand. Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431 [TBL] [Abstract][Full Text] [Related]
9. Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults. Dumurgier J; Hanseeuw BJ; Hatling FB; Judge KA; Schultz AP; Chhatwal JP; Blacker D; Sperling RA; Johnson KA; Hyman BT; Gómez-Isla T J Alzheimers Dis; 2017; 60(4):1451-1459. PubMed ID: 29036824 [TBL] [Abstract][Full Text] [Related]
10. Association of Plasma Biomarker Levels With Their CSF Concentration and the Number and Severity of Concussions in Professional Athletes. Shahim P; Zetterberg H; Simrén J; Ashton NJ; Norato G; Schöll M; Tegner Y; Diaz-Arrastia R; Blennow K Neurology; 2022 Jul; 99(4):e347-e354. PubMed ID: 35654597 [TBL] [Abstract][Full Text] [Related]
11. A comparison between tau and amyloid-β cerebrospinal fluid biomarkers in chronic traumatic encephalopathy and Alzheimer disease. Turk KW; Geada A; Alvarez VE; Xia W; Cherry JD; Nicks R; Meng G; Daley S; Tripodis Y; Huber BR; Budson AE; Dwyer B; Kowall NW; Cantu RC; Goldstein LE; Katz DI; Stern RA; Alosco ML; Mez J; McKee AC; Stein TD Alzheimers Res Ther; 2022 Feb; 14(1):28. PubMed ID: 35139894 [TBL] [Abstract][Full Text] [Related]
12. Markers of neuroinflammation associated with Alzheimer's disease pathology in older adults. Popp J; Oikonomidi A; Tautvydaitė D; Dayon L; Bacher M; Migliavacca E; Henry H; Kirkland R; Severin I; Wojcik J; Bowman GL Brain Behav Immun; 2017 May; 62():203-211. PubMed ID: 28161476 [TBL] [Abstract][Full Text] [Related]
13. Repeated Sport-Related Concussion Shows Only Minimal White Matter Differences Many Years After Playing High School Football. Terry DP; Mewborn CM; Miller LS J Int Neuropsychol Soc; 2019 Oct; 25(9):950-960. PubMed ID: 31383046 [TBL] [Abstract][Full Text] [Related]
14. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid. Forlenza OV; Aprahamian I; Radanovic M; Talib LL; Camargo MZ; Stella F; Machado-Vieira R; Gattaz WF Bipolar Disord; 2016 Feb; 18(1):63-70. PubMed ID: 26876913 [TBL] [Abstract][Full Text] [Related]
15. CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment. Mattsson N; Zetterberg H; Hansson O; Andreasen N; Parnetti L; Jonsson M; Herukka SK; van der Flier WM; Blankenstein MA; Ewers M; Rich K; Kaiser E; Verbeek M; Tsolaki M; Mulugeta E; Rosén E; Aarsland D; Visser PJ; Schröder J; Marcusson J; de Leon M; Hampel H; Scheltens P; Pirttilä T; Wallin A; Jönhagen ME; Minthon L; Winblad B; Blennow K JAMA; 2009 Jul; 302(4):385-93. PubMed ID: 19622817 [TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid tau, Aβ, and sTREM2 in Former National Football League Players: Modeling the relationship between repetitive head impacts, microglial activation, and neurodegeneration. Alosco ML; Tripodis Y; Fritts NG; Heslegrave A; Baugh CM; Conneely S; Mariani M; Martin BM; Frank S; Mez J; Stein TD; Cantu RC; McKee AC; Shaw LM; Trojanowski JQ; Blennow K; Zetterberg H; Stern RA Alzheimers Dement; 2018 Sep; 14(9):1159-1170. PubMed ID: 30049650 [TBL] [Abstract][Full Text] [Related]
17. White matter integrity is associated with cerebrospinal fluid markers of Alzheimer's disease in normal adults. Gold BT; Zhu Z; Brown CA; Andersen AH; LaDu MJ; Tai L; Jicha GA; Kryscio RJ; Estus S; Nelson PT; Scheff SW; Abner E; Schmitt FA; Van Eldik LJ; Smith CD Neurobiol Aging; 2014 Oct; 35(10):2263-71. PubMed ID: 24866404 [TBL] [Abstract][Full Text] [Related]
18. Associations between cerebral small-vessel disease and Alzheimer disease pathology as measured by cerebrospinal fluid biomarkers. Kester MI; Goos JD; Teunissen CE; Benedictus MR; Bouwman FH; Wattjes MP; Barkhof F; Scheltens P; van der Flier WM JAMA Neurol; 2014 Jul; 71(7):855-62. PubMed ID: 24818585 [TBL] [Abstract][Full Text] [Related]
19. CSF amyloid-beta and tau proteins, and cognitive performance, in early and untreated Parkinson's disease: the Norwegian ParkWest study. Alves G; Brønnick K; Aarsland D; Blennow K; Zetterberg H; Ballard C; Kurz MW; Andreasson U; Tysnes OB; Larsen JP; Mulugeta E J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1080-6. PubMed ID: 20547614 [TBL] [Abstract][Full Text] [Related]
20. CSF β-amyloid and white matter damage: a new perspective on Alzheimer's disease. Pietroboni AM; Scarioni M; Carandini T; Basilico P; Cadioli M; Giulietti G; Arighi A; Caprioli M; Serra L; Sina C; Fenoglio C; Ghezzi L; Fumagalli GG; De Riz MA; Calvi A; Triulzi F; Bozzali M; Scarpini E; Galimberti D J Neurol Neurosurg Psychiatry; 2018 Apr; 89(4):352-357. PubMed ID: 29054920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]